Retatrutide (GLP-3)

Product Details

Following the emergence of Ozempic (semaglutide) and Mounjaro (tirzepatide), Retatrutide has demonstrated even greater weight loss outcomes in clinical studies, setting a new benchmark in research.

Retatrutide represents a synthetic peptide, which research indicates functions as a triple agonist. This compound comprises a 39-amino-acid sequence, engineered as an analog to the gastric inhibitory polypeptide (GIP), with additional affinity observed towards the glucagon-like peptide-1 (GLP-1) receptor and the glucagon (GCG) receptor (1)(2).

Additional Information

• The product (substance) isn’t a food or diet supplement and is not suitable for human consumption.

• Keep out of children’s reach

• Keep container tightly closed.

• Store in a dry, cool and shaded place; protect from moisture.

• Store only in the original container.

• Avoid contact during pregnancy and breast feeding.

• Consult a doctor in the event of feeling unwell or having adverse effects related to the contact with the substance.